Search

everythinglearnresearchcommunity

for

Search:↓

AMH is a good marker for diagnosing PCOS, but global standards are needed.

The study found that specific proteins are markers of hair follicle development in human fetuses.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

PRAME is often present in Paget disease and could help in diagnosis, but more research is needed.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

CEC levels may be a useful marker for predicting prostate cancer progression.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Women with hair loss should be checked for PCOS, as it's often related and early diagnosis can help with treatment.

Discoid lupus erythematosus can be mistaken for a skin infection, complicating diagnosis and treatment.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Mycosis fungoides can have unusual symptoms and may be misdiagnosed, but specific cell markers might suggest a lower risk of worsening.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

Pilomatricomas are often linked to genetic syndromes, especially Apert syndrome, and genetic analysis is crucial for diagnosis.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Oxidative stress may play a role in alopecia areata, but depression and suicide risk are similar to healthy peers.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

PSA can help diagnose high androgen levels in women.

More research is needed to understand coat funk in Alaskan malamutes.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.